The role of pharmacological enhancement in protease inhibitor-based highly active antiretroviral therapy

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.3, 2003-03, pp. : 401-412

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protease inhibitor-based triple regimens: superior HIV therapy

Inpharma, Vol. 1, Iss. 1423, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Enhancement of Protease Inhibitor Therapy

By King J.R.

Clinical Pharmacokinetics, Vol. 43, Iss. 5, 2004-01 ,pp. : 291-310

Adis International

Access to resources Recommend Favorite

Highly Active Antiretroviral Therapy: Current State of the Art, New Agents and Their Pharmacological Interactions Useful for Improving Therapeutic Outcome

Current Pharmaceutical Design, Vol. 11, Iss. 14, 2005-05 ,pp. : 1805-1843

Bentham Science Publishers

Access to resources Recommend Favorite

Adherence and persistence with non-nucleoside reverse transcriptase inhibitor-based antiretroviral regimens

By Taneja Charu Juday Timothy Gertzog Larry Edelsberg John Correll Todd Hebden Tony Oster Gerry

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 15, 2012-10 ,pp. : 2111-2118

Informa Healthcare

Access to resources Recommend Favorite

Nevirapine-based HAART is more effective than protease inhibitor (PI)-based HAART in antiretroviral therapy-naive pregnant women with HIV infection

Inpharma, Vol. 1, Iss. 1590, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite